Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

120.15 -1.37 (-1.13%)
Official Closing Price Updated: 8:00 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
No Value In Value? Stock Market (And Sentiment Results) ↗
In a year like 2024, it is easy to forget the fact that since 1927 “Value” has outperformed “Growth” by 4.4% per year: 
Via Talk Markets
Topics Stocks / Equities
News headline image
Healthcare And Biotech Stocks Continue Their Slide ↗
Biotech shares continued their slide which began in early November and got no help from small caps which also sold off through December. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Are You Ready To Trade Biotech Stocks At The Cusp Of A Bear Market? ↗
It’s not a bear market for biotech yet it just feels that way because recent trends are down and healthcare stocks are not a stabilizing force. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
20 ETFs Primed For Unusually Big Swings On Fed Meeting Days ↗
The Federal Reserve's final meeting of the year has historically caused significant moves in 20 ETFs. A rate cut is expected, but the focus is on the Fed's forward guidance and projections. 
Via Benzinga
Topics ETFs Economy
News headline image
It’s Been A Tough Month For Healthcare Stocks ↗
It’s been a very difficult month for the healthcare sector not only because of disappointing company news but also disruption caused by the election and future policy issues. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
As The Market Churns ↗
Stocks managed to grind their way higher on the day, while rates and the dollar rebounded from yesterday’s declines. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Momentum Model For Trading SMID Biotech Stocks: Broad Rally Underway ↗
Biotech stocks are poised for a recovery in a seasonally strong period through January 2025. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Is Biotech’s Bull Run Over? Examining Election Impacts
The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup. 
Via MarketBeat
Topics ETFs Government
News headline image
What To Do After The Worst Week For Healthcare Stocks Since March 2020? ↗
The market was quiet today but we should still expect some gains through year -end albeit a bit choppy. 
Via Talk Markets
News headline image
A Must See Chart For Prudent Investors, Trump To Help Tesla Dominate, Nvidia Heat Problem ↗
To gain an edge, this is what you need to know today. 
Via Benzinga
Topics Government
News headline image
Post-Election Euphoria Turns Into Hangover; One New Swing Position ↗
In this video, I take a look at how the markets have turned around after the US election. I also review a new long setup in Pinnacle West Capital. 
Via Talk Markets
News headline image
Biotech Stocks Are Rallying: What Is Your Playbook? ↗
If you have been reading our posts you know that some of the big biotech winners have taken a hit after earnings : LLY, MRK and REGN. But ABBV, GILD, LLY, and VRTX remain among the top performers. 
Via Talk Markets
News headline image
Wednesday's Rally Followed By Friday's ↗
Everyone who follows the stock market knows that a huge rally occurred on Wednesday, and by Friday, new highs were set for many of the most important stocks, ETFs, and Indexes. Tuesday's rally off the... 
Via Talk Markets
Topics ETFs
News headline image
Smaller Cap Biotechs Are In Season: How Are We Doing? ↗
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
News headline image
Biotech Stocks Edge Higher. Could Trump 2.0 Mean More Innovation, Dealmaking? ↗
Donald Trump won his second presidency in a victory over Kamala Harris. What can investors in biotech stocks expect? 
Via Investor's Business Daily
Topics Government
News headline image
Volatility Hits Large Cap Biopharma: Active Rebalancing May Be Required ↗
A bit of earnings and election jitters roiled the market last week reordering the leaderboard in biopharma stocks. 
Via Talk Markets
News headline image
Biotech Momentum Trades For The Q4 Rally ↗
The biotech sector made an interim peak in late February followed by an active summer in very choppy trading. 
Via Talk Markets
News headline image
AskSlim Market Week - Friday, Oct. 25 ↗
An analysis and commentary on the financial markets. 
Via Talk Markets
News headline image
Healthcare Sector Update: Choppy Days Are Here Again As Yields Rise ↗
There has been a shift in healthcare stock performance by sub-sector which should be confirmed as we move through the Q3 earnings cycle. 
Via Talk Markets
News headline image
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce ↗
Healthcare sector lags despite moderate growth. Note bad news from CVS and Humana. 
Via Talk Markets
News headline image
Stocks Drop On October 7, And Are Poised To Move Lower ↗
The S&P 500 fell 90 bps today, closing at 5695, bringing the zero gamma level back into focus. This area has strong support, primarily because it separates the post-FOMC gap higher from the current... 
Via Talk Markets
Topics Stocks
News headline image
Biotech Stocks Poised For Another Big Move In Q4 ↗
The healthcare sector can be a safe haven if volatility increases. 
Via Talk Markets
News headline image
Biotech Stocks : Are You A Trader Or A Longer Term Investor? ↗
Biotech bull market is intact as indicated by large cap biopharma and the best performing funds. 
Via Talk Markets
News headline image
BCYC: A Promising Play In The Biotech Sector ↗
The long-awaited and overdue half-point cut in the federal funds rate was the impetus for the SPDR Biotech ETF to finally break above the 102-103 level. Meanwhile, Bicycle Therapeutics Plc. had a... 
Via Talk Markets
Topics ETFs
News headline image
A Biotech Breakout Will Be Led By Small Caps ↗
It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever. 
Via Talk Markets
Topics Artificial Intelligence Economy
News headline image
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital. 
Via MarketBeat
Topics ETFs Economy
News headline image
The Momentum Is Building, The Markets Are Strong - Just Don’t Chase After Extended Winners ↗
Dozens of Top Ranked Magnet stocks breaking out 
Via Talk Markets
News headline image
The Door Is Open, Time For The Fed To Act ↗
With the CPI trending down and heading in the right direction, most economists are optimistic that the door is open for the Fed to lower rates. Economists, analysts, and investors are all waiting for... 
Via Talk Markets
Topics Economy
News headline image
Stocks Hit Pause As Economic Uncertainty Tempers The Rally ↗
Stocks have been on a red-hot rally, but they’ve hit the brakes right at technical resistance, just as the charts predicted. 
Via Talk Markets
News headline image
Biotech Life Science Trades: Small Caps Are Lagging But Poised For A Q4 Rally ↗
Weaker than expected PPI up only 0.1% ignite rally with decline in services. Rate cuts imminent for September. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.